Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Januar 2014 10:10 ET | Quelle: Qu Biologics

Qu Biologics Granted Broad Australian Patent for Targeted Treatment of Multiple Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 22, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
11. Dezember 2013 11:05 ET | Quelle: Qu Biologics

Qu Biologics Appoints Rashieda Gluck as Vice President, Clinical Operations

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the...
06. Dezember 2013 05:30 ET | Quelle: Qu Biologics

Qu Biologics Granted Broad European Patent for Targeted Treatment of Multiple Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 6, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
04. Dezember 2013 09:45 ET | Quelle: Qu Biologics

Qu Biologics Appoints Dr. David Mullins as Chief Scientific Officer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the body's...
03. Dezember 2013 10:00 ET | Quelle: Qu Biologics

Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...
15. August 2013 12:42 ET | Quelle: Qu Biologics

Qu Biologics Begins Research With McMaster University to Study Chronic Inflammation Associated With Macrophage Dysfunction

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
30. Juli 2013 12:00 ET | Quelle: Qu Biologics

Qu Biologics Introduces Travel Subsidy Program for Crohn's Clinical Trial Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 30, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
03. Juli 2013 12:00 ET | Quelle: Qu Biologics

Qu Biologics Initiates Study of Site Specific Immunomodulators at Geisel School of Medicine at Dartmouth

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
13. Juni 2013 13:41 ET | Quelle: Qu Biologics

Qu Biologics Appoints Former Novartis President Mr. Robert Pelzer to its Board of Directors

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
11. Juni 2013 16:22 ET | Quelle: Qu Biologics

Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn's Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...

Vorherige Seite

Nächste Seite